A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects
Clinical trial NCT05602129 · UNKNOWN
Trial details
- NCT number
- NCT05602129
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2023-10-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.